Berbice Capital Management’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.7K Sell
100
-1,100
-92% -$133K 0.01% 83
2026
Q1
$196K Buy
1,200
+500
+71% +$76.9K 0.13% 53
2025
Q4
$122K Buy
700
+400
+133% +$73K 0.07% 65
2025
Q3
$43.2K Buy
+300
New +$36.8K 0.03% 99

Other funds holding INSM

Berbice Capital Management's INSM Position: Q2 2026 in Review

Berbice Capital Management reduced its Insmed (INSM) stake by 92% in Q2 2026, selling an estimated $133K and leaving 100 shares worth $10.7K. The position accounts for 0.01% of the portfolio, ranked #83.

Berbice Capital Management first reported a position in INSM in Q3 2025 and has held it in 4 quarters since. The position peaked at $196K in Q1 2026. 666 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Berbice Capital Management held 100 shares of Insmed worth $10.7K as of Q2 2026.
  • Berbice Capital Management sold 1,100 Insmed shares in Q2 2026, an estimated $133K.
  • Insmed made up 0.01% of Berbice Capital Management's portfolio in Q2 2026, its #83 holding.
  • Berbice Capital Management first reported a position in Insmed in Q3 2025 and has held it in 4 quarters since.
  • Berbice Capital Management's Insmed position peaked at $196K in Q1 2026.
  • 666 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Berbice Capital Management's 13F filing for Q2 2026, filed 23 Jul 2026.